This webinar will equip you with the skills to identify and manage pulmonary hypertension (PH) in patients with unexplained dyspnea. Through interactive case studies, you’ll explore real-world diagnostic challenges, learn key diagnostic techniques, and gain practical management strategies. By the end of the session, you’ll be prepared to recognize subtle signs of PH and improve patient outcomes with confidence.

Objectives

  • Describe the importance of a systematic approach to unexplained dyspnea.

  • Reinforce the importance of considering Pulmonary Hypertension in different patient presentations

  • Use case-based learning to illustrate key diagnostic steps and management recommendations

Enroll Now - it's free

Early diagnosis empowers professionals to transform lives with pulmonary hypertension.

This program has received educational funding from Merck Canada, supporting RESPIPLUS in delivering valuable Pulmonary Hypertension insights for healthcare professionals.

This webinar is only for healthcare professionals.

About our speakers

Dr. Jason Weatherald

MD, MSc, FRCPC

Dr. Jason Weatherald is a respirologist with the Southern Alberta Pulmonary Hypertension Program at the Peter Lougheed Centre. His research examines pathophysiology of pulmonary vascular disease, specifically gas exchange and pulmonary arterial hemodynamics during exercise. As a recent Canadian Vascular Network/Bayer fellowship recipient, his current research involves wave intensity analysis to describe right ventricular-pulmonary arterial interaction in patients with pulmonary hypertension and chronic thromboembolic pulmonary hypertension.
Dr. Jason Weatherald

Dr. David Langleben

MD, FRCPC

Dr. David Langleben is a Professor of Medicine at McGill University. He is the Director of the Cardiology Division of the Jewish General Hospital, and founded and directs the Centre for Pulmonary Vascular Disease, an internationally recognized resource for patient care, teaching, and research. He is a Project Director at the Lady Davis Institute for Medical Research.
Dr. David Langleben